PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 19509473-1 2009 Clinical studies have demonstrated that aldosterone receptor antagonists do improve the survival of patients with chronic heart diseases and in vitro studies have shown that canrenone blocks the proinflammatory effect of aldosterone in mononucler leukocytes (MNL). Canrenone 174-183 nuclear receptor subfamily 3 group C member 2 Homo sapiens 40-60 19509473-2 2009 The aim of the study was to compare, in the model of human MNL, the effect of potassium-sparing diuretics amiloride and canrenone, on the protein expression of p22phox, a NADPH-oxidase system subunit, that is a principal marker of production of superoxide anions. Potassium 78-87 cytochrome b-245 alpha chain Homo sapiens 160-167 19509473-2 2009 The aim of the study was to compare, in the model of human MNL, the effect of potassium-sparing diuretics amiloride and canrenone, on the protein expression of p22phox, a NADPH-oxidase system subunit, that is a principal marker of production of superoxide anions. Canrenone 120-129 cytochrome b-245 alpha chain Homo sapiens 160-167 19509473-2 2009 The aim of the study was to compare, in the model of human MNL, the effect of potassium-sparing diuretics amiloride and canrenone, on the protein expression of p22phox, a NADPH-oxidase system subunit, that is a principal marker of production of superoxide anions. Superoxides 245-262 cytochrome b-245 alpha chain Homo sapiens 160-167 19509473-5 2009 The experiments showed that aldosterone (10(-8) M) enhances the protein expression of p22phox and that its effect is reversed by co-incubation with canrenone (10(-6) M), while incubation with amiloride (10(-6) M) reduced the prooxidative effect of aldosterone at a significantly lower extent than canrenone. Aldosterone 28-39 cytochrome b-245 alpha chain Homo sapiens 86-93 19509473-5 2009 The experiments showed that aldosterone (10(-8) M) enhances the protein expression of p22phox and that its effect is reversed by co-incubation with canrenone (10(-6) M), while incubation with amiloride (10(-6) M) reduced the prooxidative effect of aldosterone at a significantly lower extent than canrenone. Canrenone 148-157 cytochrome b-245 alpha chain Homo sapiens 86-93 19509473-5 2009 The experiments showed that aldosterone (10(-8) M) enhances the protein expression of p22phox and that its effect is reversed by co-incubation with canrenone (10(-6) M), while incubation with amiloride (10(-6) M) reduced the prooxidative effect of aldosterone at a significantly lower extent than canrenone. Amiloride 192-201 cytochrome b-245 alpha chain Homo sapiens 86-93 19509473-5 2009 The experiments showed that aldosterone (10(-8) M) enhances the protein expression of p22phox and that its effect is reversed by co-incubation with canrenone (10(-6) M), while incubation with amiloride (10(-6) M) reduced the prooxidative effect of aldosterone at a significantly lower extent than canrenone. Aldosterone 248-259 cytochrome b-245 alpha chain Homo sapiens 86-93 19509473-5 2009 The experiments showed that aldosterone (10(-8) M) enhances the protein expression of p22phox and that its effect is reversed by co-incubation with canrenone (10(-6) M), while incubation with amiloride (10(-6) M) reduced the prooxidative effect of aldosterone at a significantly lower extent than canrenone. Canrenone 297-306 cytochrome b-245 alpha chain Homo sapiens 86-93 19509473-9 2009 The addition of aldosterone-receptor antagonist canrenone produced a higher inhibition than sodium channel blocker amiloride on the effect of aldosterone on p22phox protein expression. Canrenone 48-57 cytochrome b-245 alpha chain Homo sapiens 157-164 19509473-9 2009 The addition of aldosterone-receptor antagonist canrenone produced a higher inhibition than sodium channel blocker amiloride on the effect of aldosterone on p22phox protein expression. Amiloride 115-124 cytochrome b-245 alpha chain Homo sapiens 157-164 19509473-9 2009 The addition of aldosterone-receptor antagonist canrenone produced a higher inhibition than sodium channel blocker amiloride on the effect of aldosterone on p22phox protein expression. Aldosterone 16-27 cytochrome b-245 alpha chain Homo sapiens 157-164